Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F116 - The Pregnant Pause: How to Evaluate and Treat Your Pregnant Patients

Sunday, February 18; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • 1. Develop treatment plans for pregnant patients with common dermatologic diagnoses.
  • 2. Evaluate and manage melanocytic lesions in the pregnant patient.
  • 3. Recognize and treat specific dermatoses of pregnancy.

Description

Dermatologists face multiple challenges when evaluating and treating the pregnant patient. Treatment of acne and psoriasis is difficult; risks to the fetus limit the number of evidence-based studies concerning drug therapy. Concerning melanocytic lesions, do nevi change during pregnancy and if melanoma is diagnosed, is there a poor prognosis? Infections and infestations in the pregnant patient may present a risk to the mother and fetus, and treatment options may be limited. Several dermatoses are specific for pregnancy; early recognition and management may be important to prevent adverse effects on the fetus. This forum will review these topics and provide recommendations.

Disclosures

  • Driscoll, Marcia S., MD: UpToDate, Inc – O(H);
  • Grant-Kels, Jane Margaret, MD: no financial relationships exist with commercial interests.
  • Keri, Jonette Elizabeth, MD, PhD: Hoffman-La Roche Ltd. – C(Fees); Ortho Dermatologics – A(H); Pierre Fabre Dermatologie – A(H);
  • Kimball, Alexandra Boer, MD, MPH: AbbVie – C(H), I(Grants/Research Funding); Dermira – C(H); Escalier Biosciences – A(H), A(OB); Janssen Biotech – C(H); Janssen Pharmaceuticals, Inc – I(Residency/Fellowship Program Funding); Lilly ICOS LLC – C(H); Merck & Co., Inc – C(H); New Enterprise Associates – C(H); Novartis – C(H); Procter & Gamble Company – C(H); Purdue Pharma – C(H); Regeneron – C(H); Sanofi/Regeneron – C(H); UCB – C(H);
  • Murase, Jenny Eileen, MD: Dermira – C(H); Ferndale Laboratories, Inc. – C(H); Regeneron – SH(ST); UCB – C(H);
Schedule
Sunday, February 18
3:30 PM
Dr. Driscoll / Introduction/ Dr. Driscoll
3:35 PM
Dr. Kimball / Treatment of Psoriasis in the Pregnant Patient
3:55 PM
Dr. Driscoll / Dermatoses of Pregnancy
4:15 PM
Dr. Keri / Treatment of Acne in the Pregnant Patient
4:35 PM
Dr. Murase / Treatment of infections and Infestation in the Pregnant Patient
4:55 PM
Dr. Grant-Kels / Evaluation and Management of Nevi and Melanoma in the Pregnant Patient
5:15 PM
All faculty / Questions and Discussion
Event Details
  • Date
    Sunday, February 18
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 29D
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
Speakers
  • Alexandra Boer Kimball, MD, MPH, FAAD
  • Jane Margaret Grant-Kels, MD, FAAD - Handout
  • Jenny Eileen Murase, MD, FAAD - Handout
  • Jonette Elizabeth Keri, MD, PhD, FAAD - Handout